AVZO-021
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AVZO-021, covering 2025-11-19 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors [Phase 1, Phase 2]